NCT06736951 Modifying the Inpatient Environment to Reduce Delirium in Older Adults
| NCT ID | NCT06736951 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Farhaan S. Vahidy |
| Condition | Delirium |
| Study Type | INTERVENTIONAL |
| Enrollment | 10,890 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2029-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10,890 participants in total. It began in 2024-06-01 with a primary completion date of 2029-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall goal is to reduce the incidence and burden of delirium, as measured by the delirium burden index (DBI) among hospitalized older adults (≥70 years), by modifying the inpatient environment to decrease its sleep antagonism. The investigators propose to implement a multi-modal sleep hygiene (MMSH) bundle, an enhancement of a previously reported sleep-focused intervention which had 88 - 100% compliance for intervention components, and reduced ICU delirium by 50%.
Eligibility Criteria
Inclusion criteria: * Non-critically ill patients (≥70 years) * All sexes * All races and ethnicities * Admitted to the pre-specified clinical units which are part of the study Exclusion criteria (applied during analysis): * Patients with active alcohol or substance withdrawal. * Patients with acute psychiatric illness * Patients with initial admission to intensive care unit including requirement for mechanical ventilation. * Patients present on a unit at the time of unit randomization
Contact & Investigator
Farhaan Vahidy, PhD
PRINCIPAL INVESTIGATOR
The Methodist Hospital Research Institute
Frequently Asked Questions
Who can join the NCT06736951 clinical trial?
This trial is open to participants of all sexes, aged 70 Years or older, studying Delirium. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06736951 currently recruiting?
Yes, NCT06736951 is actively recruiting participants. Contact the research team at rrnair@houstonmethodist.org for enrollment information.
Where is the NCT06736951 trial being conducted?
This trial is being conducted at Baytown, United States, Houston, United States, Houston, United States, Houston, United States and 1 additional location.
Who is sponsoring the NCT06736951 clinical trial?
NCT06736951 is sponsored by Farhaan S. Vahidy. The principal investigator is Farhaan Vahidy, PhD at The Methodist Hospital Research Institute. The trial plans to enroll 10,890 participants.